- $4.08bn
- $5.05bn
- $1.72bn
- 98
- 36
- 63
- 72
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 18.65 | ||
PEG Ratio (f) | 0.64 | ||
EPS Growth (f) | 41.34% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.52 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 40.98 | ||
Price to Sales | 2.38 | ||
EV to EBITDA | 15.89 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 7.3% | ||
Return on Equity | 7.71% | ||
Operating Margin | 12.13% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1,073.44 | 1,221.08 | 1,331.28 | 1,555.66 | 1,716.6 | 1,865.89 | 1,999.13 | 6.41% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -43.08 | +30.68 | -1.75 | +36.68 | +19.33 | +61.5 | +12.02 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Directors
- Bill Sanford NEC (77)
- Joseph Dziedzic PRE (52)
- Jason Garland CFO (47)
- Joel Becker CEX (53)
- Carter Houghton CEX (52)
- Payman Khales CEX (51)
- Kirk Thor CHO (57)
- Joseph Flanagan EVP (62)
- Elizabeth Giddens SVP (50)
- Anthony Borowicz SVP (63)
- Jennifer Bolt SVP (52)
- Sheila Antrum IND (63)
- Pamela Bailey IND (72)
- Cheryl Capps IND (59)
- James Hinrichs IND (53)
- Jean Hobby IND
- Alvin Jeffers IND (47)
- Martin Maxwell IND (62)
- Filippo Passerini IND (63)
- Donald Spence IND (67)
- William Summers IND (71)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 13th, 1997
- Public Since
- September 29th, 2000
- No. of Shareholders
- 100
- No. of Employees
- 11,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange
- Shares in Issue
- 34,889,876

- Address
- 5830 Granite Parkway., Suite 1150, PLANO, 75024
- Web
- https://integer.net
- Phone
- +1 2146185243
- Contact
- Andrew Senn
- Auditors
- Deloitte & Touche LLP
Upcoming Events for ITGR
Q1 2025 Integer Holdings Corp Earnings Call
Integer Holdings Corp Annual Shareholders Meeting
Integer Holdings Corp Annual Shareholders Meeting
Q2 2025 Integer Holdings Corp Earnings Release
Similar to ITGR
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
As of Today at 21:19 UTC, shares in Integer Holdings are trading at $116.98. This share price information is delayed by 15 minutes.
Shares in Integer Holdings last closed at $116.98 and the price had moved by -1.3% over the past 365 days. In terms of relative price strength the Integer Holdings share price has underperformed the S&P500 Index by -7.19% over the past year.
The overall consensus recommendation for Integer Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInteger Holdings does not currently pay a dividend.
Integer Holdings does not currently pay a dividend.
Integer Holdings does not currently pay a dividend.
To buy shares in Integer Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $116.98, shares in Integer Holdings had a market capitalisation of $4.08bn.
Here are the trading details for Integer Holdings:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: ITGR
Based on an overall assessment of its quality, value and momentum Integer Holdings is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Integer Holdings is $149.38. That is 27.7% above the last closing price of $116.98.
Analysts covering Integer Holdings currently have a consensus Earnings Per Share (EPS) forecast of $6.06 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Integer Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -0.61%.
As of the last closing price of $116.98, shares in Integer Holdings were trading -8.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Integer Holdings PE ratio based on its reported earnings over the past 12 months is 18.65. The shares last closed at $116.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Integer Holdings' management team is headed by:
- Bill Sanford - NEC
- Joseph Dziedzic - PRE
- Jason Garland - CFO
- Joel Becker - CEX
- Carter Houghton - CEX
- Payman Khales - CEX
- Kirk Thor - CHO
- Joseph Flanagan - EVP
- Elizabeth Giddens - SVP
- Anthony Borowicz - SVP
- Jennifer Bolt - SVP
- Sheila Antrum - IND
- Pamela Bailey - IND
- Cheryl Capps - IND
- James Hinrichs - IND
- Jean Hobby - IND
- Alvin Jeffers - IND
- Martin Maxwell - IND
- Filippo Passerini - IND
- Donald Spence - IND
- William Summers - IND